H & H Pharmaceuticals SRL
H & H Pharmaceuticals reported revenue of €1.67m for the 2025 financial year (annual accounts filed with the NBB on 20 Aug 2026).
By total assets for 2025, H & H Pharmaceuticals ranks among the 100 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of H & H Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1230 % Total assets +101 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
H & H Pharmaceuticals's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 19 Jun 2024
- Year ended 31 Dec 2022filed on 18 Aug 2023
- Year ended 31 Dec 2021filed on 19 Jul 2022
H & H Pharmaceuticals's financial analysis
- Solvency58.6%sector median: 44.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of H & H Pharmaceuticals
H & H Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0759.775.660
- VAT number
- BE0759775660
- Peppol
- Registered · 0208:0759775660 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Dec 2020
- Registered office
- 1402 Nivelles
- Latest accounts
- 2025 · filed on 20 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
H & H Pharmaceuticals (SRL) has been based in Nivelles since 2020, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €1.67m, a net profit of €8.36m and equity of €27.8m. Its solvency stands at 58.6%, above the median of its sector (44.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to H & H Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Healis Holding Activities of holding companies Geel · balance sheet €53.0m
- Hyloris Pharmaceuticals Activities of holding companies Liège · balance sheet €101.5m
- MAS A.G. Manufacture of pharmaceutical preparations Sankt Vith · balance sheet €34.7m
- Palex Healthcare Group Belgium Activities of holding companies Mechelen · balance sheet €26.8m
- Hospidex Group Activities of holding companies Tienen · balance sheet €45.0m
- Medical Holding Activities of holding companies Halen · balance sheet €44.8m
- Finicoma Business and other management consultancy activities Ghent · balance sheet €83.6m
- Docpharma Manufacture of perfume and toilet preparations Hoeilaart · balance sheet €48.2m
Frequently asked questions about H & H Pharmaceuticals
What is the revenue of H & H Pharmaceuticals?
According to the 2025 annual accounts filed with the NBB, the revenue of H & H Pharmaceuticals amounts to 1,671,876 €.
What is the VAT number of H & H Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0759775660 for H & H Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0759.775.660.
Where is the registered office of H & H Pharmaceuticals?
According to the CBE register, the registered office of H & H Pharmaceuticals is in 1402 Nivelles.
What is the equity of H & H Pharmaceuticals?
At the close of the 2025 financial year, the equity of H & H Pharmaceuticals amounts to 27,771,751 €, a solvency of 58.6% of total assets.
Who manages H & H Pharmaceuticals?
The register lists 2 active mandates at H & H Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is H & H Pharmaceuticals within its sector?
By total assets for 2025, H & H Pharmaceuticals ranks among the 100 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of H & H Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →